Department of Nephrology, Beijing Jishuitan Hospital, Capital Medical University, Beijing, China.
Immun Inflamm Dis. 2023 Sep;11(9):e985. doi: 10.1002/iid3.985.
The kidney is an easily affected organ with sepsis which is a main underlying cause of acute kidney injury (AKI). Histone-modifying lysine-specific demethylase 2B (KDM2B) is involved in numerous pathological processes, such as cell senescence and tumor development. However, the role of KDM2B in sepsis-induced AKI is unclear.
To investigate the role of KDM2B on cell viability, inflammation and oxidative stress of sepsis-associated AKI, and the involved signaling pathways.
An AKI model in vitro was established through lipopolysaccharide (LPS)-induction in HK-2 cells. Western blots were performed to evaluate the expression of KDM2B, cyclooxygenase 2 (COX2), inducible nitric oxide synthase (iNOS), p65, c-Jun and c-Fos, as well as p65 phosphorylation. Cell viability was measured using CCK-8 kit. ELISA was performed to analyze the production of layered double hydroxide (LDH), tumor necrosis factor (TNF)-α, interleukin (IL)-1β, IL-18, vascular cell adhesion molecule-1 (VCAM-1), superoxide dismutase (SOD), malondialdehyde (MDA), glutathione (GSH), and H O . The qPCR was used to evaluate the transcription level of TNF-α, IL-1β, IL-18, and VCAM-1.
KDM2B knockdown alleviated LPS-induced cytotoxicity, decreased LDH release, and improved cell viability. KDM2B knockdown reduced concentration of inflammation-related molecules including TNF-α, IL-1β, IL-18, and VCAM-1, and inhibited their transcription. Moreover, KDM2B knockdown promoted the quantity of SOD and GSH, while declined the production of MDA, H O , COX2, and iNOS. Further, KDM2B played a role in LPS-induced HK-2 cell injury by activating nuclear factor κB (NF-κB) and activator protein 1 (AP-1) pathways.
KDM2B knockdown reduced cytotoxicity, inflammation and oxidative stress in LPS-induced AKI via inhibiting NF-κB and AP-1 pathways, indicating KDM2B may be a promising therapeutic target for the treatment of sepsis-associated AKI.
肾脏是容易受到败血症影响的器官,而败血症是急性肾损伤(AKI)的主要潜在原因。组蛋白修饰赖氨酸特异性去甲基酶 2B(KDM2B)参与许多病理过程,如细胞衰老和肿瘤发展。然而,KDM2B 在败血症引起的 AKI 中的作用尚不清楚。
探讨 KDM2B 在脓毒症相关 AKI 细胞活力、炎症和氧化应激中的作用及其相关信号通路。
通过脂多糖(LPS)诱导 HK-2 细胞建立 AKI 体外模型。Western blot 法检测 KDM2B、环氧化酶 2(COX2)、诱导型一氧化氮合酶(iNOS)、p65、c-Jun 和 c-Fos 以及 p65 磷酸化的表达。用 CCK-8 试剂盒测定细胞活力。ELISA 法分析层状双氢氧化物(LDH)、肿瘤坏死因子(TNF)-α、白细胞介素(IL)-1β、IL-18、血管细胞黏附分子-1(VCAM-1)、超氧化物歧化酶(SOD)、丙二醛(MDA)、谷胱甘肽(GSH)和 H O 的产生。qPCR 法评价 TNF-α、IL-1β、IL-18 和 VCAM-1 的转录水平。
KDM2B 敲低减轻 LPS 诱导的细胞毒性,减少 LDH 释放,提高细胞活力。KDM2B 敲低降低了炎症相关分子包括 TNF-α、IL-1β、IL-18 和 VCAM-1 的浓度,并抑制了它们的转录。此外,KDM2B 敲低增加了 SOD 和 GSH 的含量,降低了 MDA、H O 、COX2 和 iNOS 的产生。进一步研究表明,KDM2B 通过激活核因子κB(NF-κB)和激活蛋白 1(AP-1)通路在 LPS 诱导的 HK-2 细胞损伤中发挥作用。
KDM2B 敲低通过抑制 NF-κB 和 AP-1 通路减轻 LPS 诱导的 AKI 细胞毒性、炎症和氧化应激,表明 KDM2B 可能是治疗脓毒症相关 AKI 的有希望的治疗靶点。